Form 8-K - Current report:
SEC Accession No. 0001104659-26-071211
Filing Date
2026-06-08
Accepted
2026-06-08 09:01:47
Documents
14
Period of Report
2026-06-08
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mtva-20260608x8k.htm   iXBRL 8-K 52077
2 EX-99.1 mtva-20260608xex99d1.htm EX-99.1 36057
3 GRAPHIC mtva-20260608x8k001.jpg GRAPHIC 9107
4 GRAPHIC mtva-20260608xex99d1001.jpg GRAPHIC 16884
  Complete submission text file 0001104659-26-071211.txt   259676

Data Files

Seq Description Document Type Size
5 EX-101.SCH mtva-20260608.xsd EX-101.SCH 2668
6 EX-101.LAB mtva-20260608_lab.xml EX-101.LAB 15922
7 EX-101.PRE mtva-20260608_pre.xml EX-101.PRE 10049
17 EXTRACTED XBRL INSTANCE DOCUMENT mtva-20260608x8k_htm.xml XML 4806
Mailing Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138
Business Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138 (857) 702-9600
MetaVia Inc. (Filer) CIK: 0001638287 (see all company filings)

EIN.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37809 | Film No.: 261071168
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)